Drug Shortage Report for CLAVULIN 875
| Report ID | 180938 |
| Drug Identification Number | 02238829 |
| Brand name | CLAVULIN 875 |
| Common or Proper name | amoxicillin / clavulanate potassium tablets |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
| Strength(s) | 125MG 875MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 20s |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-13 |
| Estimated end date | 2023-03-31 |
| Actual end date | 2023-03-10 |
| Shortage status | Resolved |
| Updated date | 2023-03-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-03-11 | English | Compare |
| v5 | 2023-03-10 | French | Compare |
| v4 | 2023-03-10 | English | Compare |
| v3 | 2023-01-14 | English | Compare |
| v2 | 2023-01-13 | French | Compare |
| v1 | 2023-01-13 | English | Compare |
Showing 1 to 6 of 6